Table 1. Pathological summary of AD, control and dementia IPL samples.
| Case | Age | Sex | PMI | Braak | P/T | APOE |
|---|---|---|---|---|---|---|
| C1 | 74 | M | 2.5 | 2 | 0/3.5 | e3/e3 |
| C2 | 82 | F | 2 | 2 | 0.25/4.25 | e3/e3 |
| C3 | 91 | F | 2.5 | 3 | 1/4 | e2/e2 |
| C4 | 78 | M | 1.66 | 1 | 0/0 | e3/e3 |
| C5 | 85 | M | 3.16 | 2 | 0/4.25 | e3/e3 |
| C6 | 86 | F | 2.5 | 3 | 0/5 | e3/e3 |
| C7 | 88 | F | 3 | 2 | 0.25/2 | e3/e4 |
| C8 | 90 | F | 3 | 3 | 6.5/4.5 | e3/e3 |
| C9 | 88 | F | 2 | 4 | 0/4.5 | e3/e3 |
| C10 | 87 | F | 2.83 | 2 | 0/1.75 | e3/e3 |
| AD1 | 84 | M | 2 | 5 | 12/11.83 | e3/e4 |
| AD2 | 81 | M | 3 | 5 | 14/15 | e3/e4 |
| AD3 | 81 | M | 3 | 5 | 12.5/11 | e3/e4 |
| AD4 | 76 | M | 2.33 | 6 | 12.5/15 | e3/e3 |
| AD5 | 72 | M | 2.5 | 6 | 14/15 | e2/e3 |
| AD6 | 79 | M | 2 | 5 | 14.5/15 | e3/e3 |
| AD7 | 96 | F | 2.75 | 5 | 12.5/9.6 | e3/e3 |
| AD8 | 89 | F | 3 | 5 | 14/14.5 | e3/e4 |
| AD9 | 80 | F | 2.25 | 6 | 12.5/14.5 33 | e3/e3 |
| AD10 | 85 | F | 1.66 | 5 | 12.25/12 | e3/e3 |
| HS1 | 55 | M | 2 | 3 | 0.5/1.5 | e3/e4 |
| HS2 | 72 | M | 4.5 | 1 | 0/0 | e3/e3 |
| PD1 | 73 | F | 2.16 | 3 | 1.25/3.5 | e3/e4 |
| PD2 | 70 | M | 1.83 | 3 | 0/3.25 | e3/e3 |
| DLDH1 | 83 | F | 1.5 | 1 | 6.5/4.5 | e3/e3 |
| DLDH2 | 71 | M | 5 | 1 | 5.25/0 | e3/e3 |
C=control; AD=Alzheimer's disease; HS=hippocampal sclerosis; PD=Parkinson's dementia; DLDH=dementia lacking distinct histology; PMI=postmortem interval; P/T=plaque/tangle count.